Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Correction: ASO Author Reflections: It's Time to Take Dyspepsia Seriously.

Annals of surgical oncology·2026
Same author

ASO Visual Abstract: The Full Scope-Standardization of the Use of Endoscopy for Earlier Diagnosis of Stomach Cancer in the United States.

Annals of surgical oncology·2026
Same author

ASO Author Reflections: It's Time to Take Dyspepsia Seriously.

Annals of surgical oncology·2026
Same author

An appendiceal cancer organoid biobank identifies phenotypic evolution and druggable dependencies of peritoneal carcinomatosis.

Developmental cell·2026
Same author

The Full Scope: Standardization of the Use of Endoscopy for Earlier Diagnosis of Stomach Cancer in the USA.

Annals of surgical oncology·2026
Same author

Integrating real-time patient-reported outcomes in colorectal cancer care: development and evaluation of a concise clinical scorecard.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2026

Related Experiment Video

Updated: May 6, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

9.2K

Peritoneal debulking/intraperitoneal chemotherapy-non-sarcoma.

Kaitlyn J Kelly1, Garrett M Nash

  • 1Department of Surgery, Memorial Sloan-Kettering Cancer Center, New York, New York.

Journal of Surgical Oncology
|October 30, 2013
PubMed
Summary
This summary is machine-generated.

Cytoreductive surgery (CRS) combined with intraperitoneal chemotherapy (IPC) treats peritoneal metastasis from various cancers. This report details the rationale, techniques, and disease-specific factors for selecting patients for CRS and IPC.

Keywords:
cytoreductive surgeryearly postoperative intraperitoneal chemotherapy (EPIC)hyperthermic intraperitoneal chemotherapy (HIPEC)

More Related Videos

Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique
08:12

Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique

Published on: February 2, 2022

2.5K
Thermal Ablation for the Treatment of Abdominal Tumors
07:16

Thermal Ablation for the Treatment of Abdominal Tumors

Published on: March 7, 2011

35.8K

Related Experiment Videos

Last Updated: May 6, 2026

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
04:04

Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer

Published on: February 12, 2017

9.2K
Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique
08:12

Laparoscopic Pancreatoduodenectomy for Pancreatic Cancer Using In-Situ No-Touch Isolation Technique

Published on: February 2, 2022

2.5K
Thermal Ablation for the Treatment of Abdominal Tumors
07:16

Thermal Ablation for the Treatment of Abdominal Tumors

Published on: March 7, 2011

35.8K

Area of Science:

  • Oncology
  • Surgical Oncology
  • Cancer Treatment

Background:

  • Cytoreductive surgery (CRS) and intraperitoneal chemotherapy (IPC) are established treatments for peritoneal metastasis.
  • This approach is utilized for appendiceal, colorectal, gastric, and ovarian cancers, as well as primary peritoneal cancer.

Purpose of the Study:

  • To elucidate the rationale behind combining CRS and IPC.
  • To describe the various techniques employed in CRS and IPC.
  • To emphasize disease-specific considerations for patient selection.

Main Methods:

  • Review of existing literature and clinical practices.
  • Explanation of surgical and chemotherapeutic principles.
  • Discussion of patient stratification criteria.

Main Results:

  • CRS and IPC offer a combined therapeutic strategy for managing peritoneal carcinomatosis.
  • Techniques vary based on cancer type and extent of disease.
  • Careful patient selection is crucial for optimal outcomes.

Conclusions:

  • CRS and IPC represent a vital treatment modality for selected patients with peritoneal metastasis.
  • Understanding the rationale, techniques, and disease-specific factors is essential for successful application.
  • Further research may refine patient selection and treatment protocols.